SAGE logo

Sage Therapeutics (SAGE)

Profile

Full Name

Sage Therapeutics, Inc.

Ticker Symbol

SAGE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 18, 2014

Indexes

Not included

Website

http://www.sagerx.com

Employees

353

Key Details

Price

$7.54(+1.89%)

Market cap

$463.57M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$41.24M(-52.30% YoY)

Annual EPS

-$6.59(+27.18% YoY)

PE ratio

-

Next earnings date

Apr 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.54
SAGE price is $7.54

30-Day Relative Volume

0.64
SAGE 30-day relative volume is 0.64

Price Performance

Price Most recent change

+1.89%
SAGE price was up +1.89% on Apr 15, 2025

Price YTD change

+38.86%
SAGE price is up +38.86% since January 1st

Price 1-year change

-51.76%
SAGE price is down -51.76% year-on-year

Price 3-year change

-78.61%
SAGE price is down -78.61% over the past 3 years

Price Range

Price All-time high

$195.97
SAGE price is currently -96.15% below its historical high of $195.97

Price 3-year low

$4.62
SAGE price is currently +63.20% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$463.57M
SAGE market capitalization is $463.57 million

Market cap 3-year change

-77.74%
SAGE market capitalization is down -77.74% over the past 3 years

Market cap All-time high

$9.78B
SAGE market capitalization is currently -95.26% below its historical high of $9.78 billion

Market cap sector rank

68.26%
SAGE market capitalization is higher than 68.26% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.16%
SAGE shares outstanding is up +2.16% year-on-year

Shares Outstanding 3-Year Change

+4.09%
SAGE shares outstanding is up +4.09% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.18
SAGE beta is 1.18

200-day SMA

$7.53
SAGE price is currently +0.12% above its 200-day simple moving average

50-day SMA

$7.49
SAGE price is currently +0.71% above its 50-day simple moving average

RSI

51.52
SAGE 14-day relative strength index is 51.52

Volume

0.64
SAGE 30-day relative volume is 0.64

ATR

$0.39
SAGE average true range is $0.39

10-day Historical Volatility

74.14%
SAGE 10-day historical volatility is 74.14%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$41.24M
SAGE annual revenue is $41.24 million

Revenue Analysts estimate

$82.63M
SAGE annual revenue is currently -50.09% lower than the consensus analysts' forecast

Revenue 1-year change

-52.3%
SAGE annual revenue is down -52.3% year-on-year

Revenue Sector rank

44.69%
SAGE annual revenue is higher than 44.69% of companies in Healthcare sector

EPS

EPS

-$6.59
SAGE annual earnings per share is -$6.59

EPS Analysts estimate

-$3.70
SAGE annual earnings per share is currently +78.11% higher than the consensus analysts' forecast

EPS 1-year change

+27.18%
SAGE annual earnings per share is up +27.18% year-on-year

EPS Sector rank

15.66%
SAGE annual earnings per share is higher than 15.66% of companies in Healthcare sector

Profit

Gross profit

$31.80M
SAGE annual gross profit is $31.80 million

Gross margin

77.10%
SAGE annual gross profit margin is 77.10%

Operating profit

-$410.52M
SAGE annual operating income is -$410.52 million

Operating margin

-995.36%
SAGE annual operating profit margin is -995.36%

Net income

-$400.67M
SAGE annual net profit is -$400.67 million

Net margin

-971.48%
SAGE annual net profit margin is -971.48%

Expenses

Total expenses

$451.76M
SAGE annual total expenses is $451.76 million

Operating expenses

$442.31M
SAGE annual total operating expenses is $442.31 million

Cost of goods sold

$9.44M
SAGE annual cost of goods sold is $9.44 million

Selling, general & administrative expenses

$216.42M
SAGE annual SGA is $216.42 million

Depreciation and amortization

$1.03M
SAGE annual depreciation & amortization is $1.03 million

Interest expense

-
SAGE annual interest expense value is unknown

Income tax

-
SAGE annual income tax value is unknown

EBIT & EBITDA

EBIT

-$410.52M
SAGE annual earnings before interest & taxes is -$410.52 million

EBITDA

-$409.49M
SAGE annual EBITDA is -$409.49 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$547.22M
SAGE annual total assets is $547.22 million

Non current assets

$15.92M
SAGE annual long term assets is $15.92 million

Current assets

$531.30M
SAGE annual total current assets is $531.30 million

Cash and cash equivalents

$81.02M
SAGE annual cash & cash equivalents is $81.02 million

Accounts receivable

-
SAGE annual accounts receivable value is unknown

Inventory

-
SAGE annual inventory value is unknown

Liabilities

Total liabilities

$82.13M
SAGE annual total liabilities is $82.13 million

Long term liabilities

$10.52M
SAGE annual total long term liabilities is $10.52 million

Current liabilities

$71.61M
SAGE annual total current liabilities is $71.61 million

Accounts payable

$12.70M
SAGE annual accounts payable is $12.70 million

Debt

Total debt

$11.84M
SAGE annual total debt is $11.84 million

Total debt 1-year change

+129.16%
SAGE annual total debt is up +129.16% year-on-year

Long term debt

$10.52M
SAGE annual long term debt is $10.52 million

Short term debt

$1.32M
SAGE annual short term debt is $1.32 million

Equity & Capital

Shareholders equity

$465.09M
SAGE annual stockholders equity is $465.09 million

Book value

$465.09M
SAGE annual book value is $465.09 million

Retained earnings

-$2.97B
SAGE annual retained earnings is -$2.97 billion

Working capital

$459.69M
SAGE annual working capital is $459.69 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$267.19M
SAGE annual cash flow from operations is -$267.19 million

Cash from operations 1-year change

+50.57%
SAGE annual cash flow from operations is up +50.57% year-on-year

Cash from investing

$266.68M
SAGE annual cash flow from investing activities is $266.68 million

Cash from investing 1-year change

-39.79%
SAGE annual cash flow from investing activities is down -39.79% year-on-year

Cash from financing

$10.66M
SAGE annual cash flow from financing activities is $10.66 million

Cash from financing 1-year change

+76.92%
SAGE annual cash flow from financing activities is up +76.92% year-on-year

CAPEX

CAPEX

-
SAGE annual capital expenditures value is unknown

CAPEX 1-year change

-
SAGE annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$267.19M
SAGE annual free cash flow is -$267.19 million

Free cash flow 1-year change

+50.62%
SAGE annual free cash flow is up +50.62% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

77.10%
SAGE annual gross profit margin is 77.10%

Operating margin

-995.36%
SAGE annual operating profit margin is -995.36%

Net margin

-971.48%
SAGE annual net profit margin is -971.48%

ROA & ROE

ROA

-56.06%
SAGE annual return on assets is -56.06%

ROE

-63.37%
SAGE annual return on equity is -63.37%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SAGE price to earnings ratio value is unknown

PE ratio Sector rank

-
SAGE price to earnings ratio is unknown

PB Ratio

PB ratio

1.00
SAGE price to book ratio is 1.00

PB ratio Sector rank

44.28%
SAGE price to book ratio is higher than 44.28% of companies in Healthcare sector

PS Ratio

PS ratio

11.24
SAGE price to sales ratio is 11.24

PS ratio Sector rank

80.77%
SAGE price to sales ratio is higher than 80.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$394.38M
SAGE enterprise value is $394.38 million

Enterprise value Sector rank

66.42%
SAGE enterprise value is higher than 66.42% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.96
SAGE EV/EBITDA is -0.96

EV/EBITDA Sector rank

43.86%
SAGE EV/EBITDA is higher than 43.86% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.42
SAGE annual current ratio is 7.42

Quick ratio

-
SAGE annual quick ratio value is unknown

Leverage

Debt to equity

0.00
SAGE annual debt to equity ratio is 0.00

Interest coverage ratio

-
SAGE annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

1
SAGE piotroski f-score is 1

Altman Z-Score

-5.60
SAGE altman z-score is -5.60

Analyst ratings

Recent major analysts updates

Feb 12, 25 Wedbush
Neutral
Feb 12, 25 Scotiabank
Sector Outperform
Feb 12, 25 Needham
Hold
Feb 12, 25 HC Wainwright & Co.
Neutral
Feb 12, 25 Canaccord Genuity
Hold
Jan 2, 25 Piper Sandler
Overweight
Dec 16, 24 Stifel
Hold
Nov 21, 24 TD Cowen
Hold
Nov 21, 24 RBC Capital
Sector Perform
Nov 20, 24 Needham
Hold

Institutional Ownership

Similar stocks

SVA logo
Sinovac Biotech (SVA)
TYRA logo
Tyra Biosciences (TYRA)
RLAY logo
Relay Therapeutics (RLAY)
TALK logo
Talkspace (TALK)
TLRY logo
Tilray Brands (TLRY)
CCRN logo
Cross Country Healthcare (CCRN)
CGEM logo
Cullinan Oncology (CGEM)
CTKB logo
Cytek Biosciences (CTKB)
MDRX logo
Veradigm (MDRX)
  • What is the ticker symbol for Sage Therapeutics?
  • Does Sage Therapeutics pay dividends?
  • What sector is Sage Therapeutics in?
  • What industry is Sage Therapeutics in?
  • What country is Sage Therapeutics based in?
  • When did Sage Therapeutics go public?
  • Is Sage Therapeutics in the S&P 500?
  • Is Sage Therapeutics in the NASDAQ 100?
  • Is Sage Therapeutics in the Dow Jones?
  • When was Sage Therapeutics's last earnings report?
  • When does Sage Therapeutics report earnings?
  • Should I buy Sage Therapeutics stock now?

What is the ticker symbol for Sage Therapeutics?

The ticker symbol for Sage Therapeutics is NASDAQ:SAGE

Does Sage Therapeutics pay dividends?

No, Sage Therapeutics does not pay dividends

What sector is Sage Therapeutics in?

Sage Therapeutics is in the Healthcare sector

What industry is Sage Therapeutics in?

Sage Therapeutics is in the Biotechnology industry

What country is Sage Therapeutics based in?

Sage Therapeutics is headquartered in United States

When did Sage Therapeutics go public?

Sage Therapeutics's initial public offering (IPO) was on July 18, 2014

Is Sage Therapeutics in the S&P 500?

No, Sage Therapeutics is not included in the S&P 500 index

Is Sage Therapeutics in the NASDAQ 100?

No, Sage Therapeutics is not included in the NASDAQ 100 index

Is Sage Therapeutics in the Dow Jones?

No, Sage Therapeutics is not included in the Dow Jones index

When was Sage Therapeutics's last earnings report?

Sage Therapeutics's most recent earnings report was on Feb 11, 2025

When does Sage Therapeutics report earnings?

The next expected earnings date for Sage Therapeutics is Apr 25, 2025

Should I buy Sage Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page